Furthermore, we still have an incomplete understanding of how the comprehensive immune control by cytotoxic lymphocytes against EBV is initiated; even so, EBV is the prototypic viral pathogen that elicits CD8+ T cell lymphocytosis during symptomatic infection in IM patients. The gene discussed is CD8A; the disease is infection.